Georgia § 49-4-159-2 [Repealed Effective 12/31/2025] Remote maternal health clinical services; reporting; termination

Georgia Statutes

§ 49-4-159-2 — [Repealed Effective 12/31/2025] Remote maternal health clinical services; reporting; termination

Georgia § 49-4-159-2

Title49

This text of Georgia § 49-4-159-2 ([Repealed Effective 12/31/2025] Remote maternal health clinical services; reporting; termination) is published on Counsel Stack Legal Research, covering Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

O.C.G.A. § 49-4-159-2 (2026).

Text

(a)(1) As used in this Code section, the term "remote maternal health clinical services" means the use of digital technology:

(A)To collect medical and other forms of health data from a patient and electronically transmitting that information securely to a healthcare provider in a different location for interpretation and recommendation; and (B) Through a device that is compliant with the federal Health Insurance Portability and Accountability Act of 1996 and approved by the federal Food and Drug Administration.

(2)Such term includes a device that:

(A)Performs remote fetal monitoring, including maternal heart rate, fetal heart rate, amniotic fluid, placenta location, fetal presentation, tone, and movement;

(B)Measures physiological data, including blood pressure, pulse, pulse oximetry

Free access — add to your briefcase to read the full text and ask questions with AI

(a) (1) As used in this Code section, the term "remote maternal health clinical services" means the use of digital technology: (A) To collect medical and other forms of health data from a patient and electronically transmitting that information securely to a healthcare provider in a different location for interpretation and recommendation; and (B) Through a device that is compliant with the federal Health Insurance Portability and Accountability Act of 1996 and approved by the federal Food and Drug Administration. (2) Such term includes a device that: (A) Performs remote fetal monitoring, including maternal heart rate, fetal heart rate, amniotic fluid, placenta location, fetal presentation, tone, and movement; (B) Measures physiological data, including blood pressure, pulse, pulse oximetry, weight, blood glucose levels, or other such data determined to be medically necessary; (C) Uses remote non-stress test technology; (D) Uses remote ultrasound technology; or (E) Uses Doppler effect technology. (b) No later than October 31, 2025, the department shall submit a detailed written report on the provision of remote maternal health clinical services for Fiscal Year 2024 and Fiscal Year 2025 to recipients of medical assistance who meet eligibility criteria established by the department to the Governor, Lieutenant Governor, Speaker of the House of Representatives, and the chairpersons of the House Committee on Health, the Senate Health and Human Services Committee, the House Committee on Appropriations, and the Senate Appropriations Committee. (c) This Code section shall stand repealed by operation of law on December 31, 2025.